ArticleAnnals of translational medicine2020

MET immunochemistry: a reliable screening tool for MET exon 14 skipping mutations in non-small cell lung cancer?

Melinda A Pruis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.